Subject: Upcoming Funding Opportunities
From: The Cancer Imaging Program <[email-masked]>
To: [email-masked]
Date: Thu, 08 Apr 2021 19:57:58 +0000

CIP - Cancer Imaging Program

CIP would like to share several opportunities of potential interest to the imaging community. They are planned for FY2022 and were recently approved by the NCI Board of Scientific advisors:

Radiation Oncology-Biology Integration Network (ROBIN) (U54, new RFA).  Details can be found in NOT-CA-21-045.

Canine Cancer Immunotherapy Network (K9CIN) (U01, new RFA).

Acquired Resistance to Therapy Network (ARTNet) (U54 and U24, Re-issue RFA).

New SBIR Contract Topics including:  Ultra-Fast Dose Rate (FLASH) Radiation, Detectors and Safety Systems; Development of Senotherapeutic Agents for Cancer Treatment;

These FOAs will be published in the June-August 2021 timeframe with applications respectively being in the May 2022 council.  Videocasts and PDF versions of these and other BSA presentations can be found here.

Stay Connected with the National Cancer Institute

Chat with us: LiveHelp       Call us: 1-800-4-CANCER (1-800-422-6237)

SUBSCRIBER SERVICES:
Manage Subscriptions  |  Help

This email was sent to [email-masked] using GovDelivery Communications Cloud on behalf of: National Cancer Institute · BG 9609 MSC 9760 · 9609 Medical Center Drive · Bethesda, MD 20892